Literature DB >> 26285646

Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors.

Federica Sereni1, Massimo Dal Monte1, Luca Filippi2, Paola Bagnoli3.   

Abstract

Complex interactions between tumor cells and their surrounding compartment are strongly influenced by the host in which the tumor grows. In melanoma, for instance, stress-associated norephinephrine (NE), acting at β-adrenergic receptors (β-ARs), stimulates melanoma cell proliferation and tumor angiogenesis. Among β-ARs, β3-ARs play a role acting not only at tumor cells but also at non-neoplastic stromal cells within the melanoma. In the present study, we used a murine model of B16 melanoma to evaluate the role of the host β1- and β2-ARs in melanoma growth and we determined whether the role of β3-ARs can be influenced by the absence of stromal β1- and β2-ARs. As compared to wild-type mice, β1/2-AR knockout mice displayed (i) increased intratumoral levels of both NE and β3-ARs, as evidentiated at both messenger and protein levels; (ii) increased tumor vascularization; (iii) decreased tumor cell proliferation but increased tumor cell apoptosis; and (iv) increased responsiveness to intratumoral injection of the β3-AR blocker L-748,337 in terms of decrease in tumor growth, tumor vascular response, tumor cell proliferation, and increase in tumor cell death. These findings together validate the role of β-AR signaling in melanoma microenvironment suggesting that non-neoplastic stromal cells may be targeted by β-AR-related drugs. The additional fact that β3-ARs play an important role in melanoma growth suggests selective β3-AR antagonists as important proapoptotic agents.

Entities:  

Keywords:  Antibody validation; Catecholamines; Melanoma; β-adrenergic receptors

Mesh:

Substances:

Year:  2015        PMID: 26285646     DOI: 10.1007/s00210-015-1165-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  57 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.

Authors:  Donald M Lamkin; Erica K Sloan; Ami J Patel; Beverley S Chiang; Matthew A Pimentel; Jeffrey C Y Ma; Jesusa M Arevalo; Kouki Morizono; Steve W Cole
Journal:  Brain Behav Immun       Date:  2012-01-25       Impact factor: 7.217

3.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

Review 4.  Molecular pathways: beta-adrenergic signaling in cancer.

Authors:  Steven W Cole; Anil K Sood
Journal:  Clin Cancer Res       Date:  2011-12-20       Impact factor: 12.531

5.  Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.

Authors:  Martin C Michel; Hana Cernecka; Peter Ochodnicky
Journal:  Eur J Pharmacol       Date:  2011-02-12       Impact factor: 4.432

6.  Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

Authors:  Artur Wnorowski; Mariola Sadowska; Rajib K Paul; Nagendra S Singh; Anna Boguszewska-Czubara; Lucita Jimenez; Kotb Abdelmohsen; Lawrence Toll; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2015-02-20       Impact factor: 4.315

7.  Potent and selective human beta(3)-adrenergic receptor antagonists.

Authors:  M R Candelore; L Deng; L Tota; X M Guan; A Amend; Y Liu; R Newbold; M A Cascieri; A E Weber
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

8.  Norepinephrine-glucocorticoids interaction does not annul the opposite effects of the individual treatments on cellular plasticity in neuroblastoma cells.

Authors:  Shiri P Yaniv; Dorit Ben-Shachar; Ehud Klein
Journal:  Eur J Pharmacol       Date:  2008-08-20       Impact factor: 4.432

Review 9.  Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy.

Authors:  Rajesh N Gacche; Rohan J Meshram
Journal:  Biochim Biophys Acta       Date:  2014-05-13

10.  Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.

Authors:  Vincenzo De Giorgi; Sara Gandini; Marta Grazzini; Silvia Benemei; Niccolò Marchionni; Pierangelo Geppetti
Journal:  Mayo Clin Proc       Date:  2013-11       Impact factor: 7.616

View more
  14 in total

Review 1.  β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β3 -adrenoceptors.

Authors:  Massimo Dal Monte; Maura Calvani; Maurizio Cammalleri; Claudio Favre; Luca Filippi; Paola Bagnoli
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

2.  Easy-to-use strategy for reference gene selection in quantitative real-time PCR experiments.

Authors:  Stefanie Klenke; Kristina Renckhoff; Andrea Engler; Jürgen Peters; Ulrich H Frey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-20       Impact factor: 3.000

Review 3.  The Role of β-Blockers in Melanoma.

Authors:  Vincenzo De Giorgi; Pierangelo Geppetti; Chiara Lupi; Silvia Benemei
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-03       Impact factor: 4.147

4.  Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice.

Authors:  Sonia Maccari; Maria Buoncervello; Andrea Rampin; Massimo Spada; Daniele Macchia; Luciana Giordani; Tonino Stati; Claudia Bearzi; Liviana Catalano; Roberto Rizzi; Lucia Gabriele; Giuseppe Marano
Journal:  Br J Pharmacol       Date:  2016-11-30       Impact factor: 8.739

5.  β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma.

Authors:  Maura Calvani; Gennaro Bruno; Massimo Dal Monte; Romina Nassini; Filippo Fontani; Arianna Casini; Lorenzo Cavallini; Matteo Becatti; Francesca Bianchini; Francesco De Logu; Giulia Forni; Giancarlo la Marca; Lido Calorini; Paola Bagnoli; Paola Chiarugi; Alberto Pupi; Chiara Azzari; Pierangelo Geppetti; Claudio Favre; Luca Filippi
Journal:  Br J Pharmacol       Date:  2019-05-09       Impact factor: 8.739

6.  Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.

Authors:  Luca Filippi; Giacomo Cavallaro; Elettra Berti; Letizia Padrini; Gabriella Araimo; Giulia Regiroli; Valentina Bozzetti; Chiara De Angelis; Paolo Tagliabue; Barbara Tomasini; Giuseppe Buonocore; Massimo Agosti; Angela Bossi; Gaetano Chirico; Salvatore Aversa; Roberta Pasqualetti; Pina Fortunato; Silvia Osnaghi; Barbara Cavallotti; Maurizio Vanni; Giulia Borsari; Simone Donati; Giuseppe Nascimbeni; Giancarlo la Marca; Giulia Forni; Silvano Milani; Ivan Cortinovis; Paola Bagnoli; Massimo Dal Monte; Anna Maria Calvani; Alessandra Pugi; Eduardo Villamor; Gianpaolo Donzelli; Fabio Mosca
Journal:  BMC Pediatr       Date:  2017-07-14       Impact factor: 2.125

7.  Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.

Authors:  Clarissa N Amaya; Mariah Perkins; Andres Belmont; Connie Herrera; Arezo Nasrazadani; Alejandro Vargas; Thuraieh Khayou; Alexa Montoya; Yessenia Ballou; Dana Galvan; Alexandria Rivas; Steven Rains; Luv Patel; Vanessa Ortega; Christopher Lopez; William Chow; Erin B Dickerson; Brad A Bryan
Journal:  Oncoscience       Date:  2018-04-29

Review 8.  The Autonomic Regulation of Tumor Growth and the Missing Links.

Authors:  Maricris Bautista; Anand Krishnan
Journal:  Front Oncol       Date:  2020-05-13       Impact factor: 6.244

Review 9.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

10.  β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function.

Authors:  Giuseppe Procino; Monica Carmosino; Serena Milano; Massimo Dal Monte; Giorgia Schena; Maria Mastrodonato; Andrea Gerbino; Paola Bagnoli; Maria Svelto
Journal:  Kidney Int       Date:  2016-05-17       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.